SurgoCap Partners LP

Q3 2024 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2024
Date filed
11/14/2024
Form type
13F-HR
Num holdings
12
Total value ($000)
$2,002,520
Net value change ($000)
+292,888 (17.1%)
New positions
2
Sold out positions
4
Turnover %
37.3%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
META 173,932 NEW
CRS 105,756 NEW
GEV 88,507 41.8%
GEHC 70,671 78.8%
AAPL 65,325 65.0%
LPLA 28,886 18.9%
SNPS 25,271 21.5%
MCK 19,466 6.9%
GWRE 14,115 12.6%
Top Reduces (Value $000, Stocks/ETFs)
QCOM -124,310 -100.0%
NVDA -105,949 -100.0%
CNM -101,562 -100.0%
MSFT -87,349 -100.0%
BX -5,256 -4.1%
NU -2,103 -2.2%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 127,490 (6.4% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type